Aquedeon Medical was founded with the mission of reducing circulatory arrest time during open cardiothoracic surgery. Our technology, the Duett™ Vascular Graft System, was uniquely designed to standardize and simplify open surgical vascular procedures with the goal of providing cardiothoracic surgeons and vascular surgeons a means to treat the target vessels effectively and more efficiently. The Duett Vascular Graft System is currently not approved or cleared for use or distribution in any geography.
Company’s Keywords:
<4
<
<2018